• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number ONXAAP-27/29
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Aneurysm (1708)
Event Date 12/10/2018
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to implant registration cards returned from the hospital, onxaap-27/29, (b)(4), implanted (b)(6) 2018, explanted (b)(4) 2018 and replaced with onxaap-27/29, (b)(4).Additional information received: patient had bentall, ascending and full arch for type a dissection and came back for root false aneurysm due to infection and had to have his root done again.This is totally unrelated to the valve as it was functioning well.No evidence of endocarditis.
 
Manufacturer Narrative
The manufacturing records for the onxaap-27/29 sn: (b)(4) were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were noted.Onxaap- 27/29 sn: (b)(4) was implanted on (b)(6) 2018 in the aortic position of a 54 year old male and replaced on (b)(6) 2018 (245 days post-implant) with another onxaap-27/29 sn: (b)(4), as observed in the manufacturer 's device tracking database.Follow-up information from the field received january 11, 2019: "pt had bentall, ascending and full arch for type a dissection in august 2018 and came back for root false aneurysm due to infection and had to have his root done again.This is totally unrelated to the valve as it was functioning well.No evidence of endocarditis.¿ the report from the field serves to identify the reason for explant to be due to a false aneurysm as a result of infection, but without evidence of endocarditis.The aortic root, apart from the valve which was functioning normally, required reconstruction/replacement.There is no evidence that the valve contributed to the need for replacement.Nevertheless, the instructions for use [ifu] note that reoperation and explantation of the prosthetic valve are risks associated with a complication.The ifu also lists false aneurysm as a potential adverse event, which, in this case, precipitated the reoperation.The development of a false aneurysm requiring restoration of the aortic root necessitated the replacement of the on-x ascending aortic prosthesis.There is no evidence that the on-x valve contributed to the cause of the adverse event.No further action is required.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
 
Event Description
According to implant registration cards returned from the hospital, onxaap-27/29 serial number: (b)(4) implanted on (b)(6) 2018, explanted on (b)(6) 2018 and replaced with onxaap-27/29 sn: (b)(4).Additional information received: patient had bentall, ascending and full arch for type a dissection and came back for root false aneurysm due to infection and had to have his root done again.This is totally unrelated to the valve as it was functioning well.No evidence of endocarditis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
MDR Report Key8242037
MDR Text Key132913501
Report Number1649833-2019-00001
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberONXAAP-27/29
Was Device Available for Evaluation? No
Distributor Facility Aware Date01/03/2019
Date Manufacturer Received01/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Other; Required Intervention;
Patient Age54 YR
-
-